One hundred and eight patients with ileostomies were investigated for cholelithiasis at routine annual review in a large Ileostomy Clinic. Gallstones were demonstrated in 24-5%, which is three times ...
Liver disease is largely preventable with only approximately 5% of liver disease is attributable to autoimmune disorders (OHIED, 2023). People with the leading cause of cirrhosis, alcohol misuse, the ...
Background Mounting epidemiological evidence supports a role for phosphatase and tensin homologue (PTEN)-T cell leukaemia 1 (Tcl1) signalling deregulation in hepatocarcinogenesis. Objective To ...
Methods A retrospective analysis of LTs from the Birmingham Liver unit (January 2013 to May 2023) with a minimum follow-up of 6 months was performed. Risk factors present at listing were recorded ...
Background and Aims Hepatocellular carcinoma (HCC) remains a leading cause of liver-related morbidity and mortality. Although liver transplantation (LT) is a radical therapy that improves survival, ...
In 2019, a multi-centred UK study procured residual blood samples from several ED sites, including Liverpool, finding high levels of active HCV, often in patients unaware of their HCV status. ED ...
Introduction Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, 90% of cases are associated with chronic liver disease. Early detection and management of HCC remain ...
2 Institute for Global Health, University College London, London, UK 3 Institute for Liver and Digestive Health, University College London, London, UK Many factors associated with disengagement from ...
Introduction Despite treatment initiatives to meet the WHO target of eliminating hepatitis C virus (HCV) by 2030, many patients with HCV in the UK are not yet linked to specialist services or treated.
Background and Aims Transjugular intrahepatic portosystemic shunts (TIPSS) are increasingly used for the management of portal hypertensive complications. Outcomes for patients undergoing TIPSS for the ...
Introduction Transient elastography (TE) is a non-invasive means of identifying liver fibrosis and cirrhosis. National Institute for Health and Care Excellence (NICE) guidelines recommend TE in adults ...
Introduction HBV is a silent disease, often diagnosed through targeted screening. Blood borne virus (BBV) screening has been introduced in Emergency Departments (ED), commencing at our site in ...